BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34861804)

  • 1. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Lim XR; Chew POK; Lim GH; Low YL; Lim JWP; Ong HN; Law WG; Tan JWL; Thong BY; Chia FL; Lian TY; Chan GYL; Chan MT; Koh ET; Kong KO; Howe HS
    Lupus; 2022 Dec; 31(14):1759-1769. PubMed ID: 36218127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
    Chalhoub NE; Luggen ME
    Lupus; 2019 Jan; 28(1):51-58. PubMed ID: 30482092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    Nantes SG; Su J; Dhaliwal A; Colosimo K; Touma Z
    J Rheumatol; 2017 Nov; 44(11):1583-1589. PubMed ID: 28864643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in SLE: development of a screening tool.
    Adhikari T; Piatti A; Luggen M
    Lupus; 2011 Oct; 20(11):1142-6. PubMed ID: 21676920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Tayer-Shifman OE; Yuen K; Green R; Kakvan M; Katz P; Bingham KS; Diaz-Martinez JP; Ruttan L; Wither JE; Tartaglia MC; Su J; Bonilla D; Choi MY; Appenzeller S; Barraclough M; Beaton DE; Touma Z
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):569-577. PubMed ID: 35724303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Paez-Venegas N; Jordan-Estrada B; Chavarria-Avila E; Perez-Vazquez F; Gómez-Bañuelos E; Medina-Dávalos R; Ontiveros-González JÁ; Diaz-Rubio GI; Navarro-Hernandez RE; Vázquez-Del Mercado M
    J Clin Rheumatol; 2019 Dec; 25(8):325-328. PubMed ID: 31764492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
    Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
    Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life.
    Kim MY; Sen D; Drummond RR; Brandenburg MC; Biesanz KL; Kim AH; Eisen SA; Baum CM; Foster ER
    Lupus; 2021 Jun; 30(7):1100-1107. PubMed ID: 33794707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the Cutoff of the MoCA too High? Longitudinal Data From Highly Educated Older Adults.
    Elkana O; Tal N; Oren N; Soffer S; Ash EL
    J Geriatr Psychiatry Neurol; 2020 May; 33(3):155-160. PubMed ID: 31500493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia.
    Poptsi E; Moraitou D; Eleftheriou M; Kounti-Zafeiropoulou F; Papasozomenou C; Agogiatou C; Bakoglidou E; Batsila G; Liapi D; Markou N; Nikolaidou E; Ouzouni F; Soumpourou A; Vasiloglou M; Tsolaki M
    J Geriatr Psychiatry Neurol; 2019 Sep; 32(5):265-274. PubMed ID: 31159629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus.
    Julian LJ; Yazdany J; Trupin L; Criswell LA; Yelin E; Katz PP
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):448-54. PubMed ID: 22162414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.